ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1387

Macrovascular Dysfunction and Its Clinical Implication in Systemic Sclerosis

Devender Bairwa1, Chengappa Kavadichanda2, sanket Shah3, Anoop Mathew1, saikumar dunga3, Aishwarya Gopal3, Molly Mary Thabah1 and VirSingh Negi1, 1Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India, 2JIPMER, Pondicherry, India, 3Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India

Meeting: ACR Convergence 2021

Keywords: Disability, hand, Raynaud's phenomenon, Systemic sclerosis, Ulcers

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 8, 2021

Session Title: Systemic Sclerosis & Related Disorders – Clinical Poster II (1364–1390)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Microvascular dysfunction is a key and determining feature of scleroderma (SSc). But contrary to earlier belief there is emerging evidence to suggest co-occurrence of macrovascular dysfunction. The clinical implication of macrovascular dysfunction in SSc is unknown and its correlation with microvascular dysfunction is inconclusive. Therefore the objectives of this study were to assess the prevalence and clinical impact of macrovascular dysfunction in a cohort of SSc. To study the correlation between macrovascular dysfunction as assessed by percent change in flow mediated vasodilation (FMD) of brachial artery and microvascular dysfunction as assessed by nail fold capillaroscopy (NFC) findings in SSc.

Methods: Cross-sectional comparative study enrolled SSc patients (n=59) and age & gender matched healthy controls (n=64). FMD change was calculated using standard USG probe (6 MHz) in right brachial diameter from the average of 3 consecutive end diastolic frames. NFC was performed using portable nail fold capillary microscope at 800X magnification. Clinical features of SSc were compared between SSc patients with and without macrovascular dysfunction.

Results: SSc had significantly (p < 0.001) lower FMD change (median-4.54, IQR 3.13-8.82) compared to healthy controls (median – 10.30, IQR 8.33-13.16). Two out of every three SSc patients 43/59 (66.2%) had impaired FMD. We replicated significantly (p-value< 0.0001) lower capillary density (median – 3.19, IQR 2.38-3.94) in SSc compared to healthy controls (median – 7.56, IQR 7.06-8.0) (Table 01). Impairment in FMD was not associated with Raynaud’s phenomenon, digital gangrene, digital ulcer, acro-osteolysis or pulmonary hypertension suggesting need for a prospective study to identify the implications (Table 02). Magnitude of NFC findings and FMD changes did not corelate with the impairment in FMD among SSc patients (Fig. 01)

Conclusion: About 2/3rd of patients with SSc have macrovascular complications but their clinical implications may need long term prospective follow up. Macrovascular and microvascular dysfunction appears to be independent of each other in SSc.

Table 1: Comparison of parameters between the SSc patients with healthy controls (*P value < 0.001)

Table 2: comparison of macrovascular complication between SSc patients with or without impaired FMD

Fig.1: Correlation of FMD percent change with (a) average capillary density (b) abnormal capillaries and (c) % avascular area


Disclosures: D. Bairwa, None; C. Kavadichanda, None; s. Shah, None; A. Mathew, None; s. dunga, None; A. Gopal, None; M. Thabah, None; V. Negi, None.

To cite this abstract in AMA style:

Bairwa D, Kavadichanda C, Shah s, Mathew A, dunga s, Gopal A, Thabah M, Negi V. Macrovascular Dysfunction and Its Clinical Implication in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 10). https://acrabstracts.org/abstract/macrovascular-dysfunction-and-its-clinical-implication-in-systemic-sclerosis/. Accessed July 2, 2022.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/macrovascular-dysfunction-and-its-clinical-implication-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies